跳至主要内容
临床试验/ACTRN12623000279628
ACTRN12623000279628招募中未知

Genetic and Biochemical Predictors of Pelvic Organ Prolapse

niversity of Otago0 个研究点目标入组 1,200 人开始时间: 2023年3月15日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
1,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
Female

入选标准

  • All participants (surgical and genome-only study):
  • 1.Aged between 18 and 55
  • 2. Women (including all people with female reproductive anatomy [but no history of male hormone therapy])
  • 3.Able to give informed consent for participation
  • Prolapse group for both studies:
  • 1. A previously or currently diagnosed POP-Q grade 3 or 4 pelvic organ prolapse
  • Surgical prolapse group:
  • 1.Undergoing planned pelvic prolapse repair surgery
  • Surgical control group:
  • 1. Undergoing a planned abdominal hysterectomy.
  • No further specific, inclusion criteria for the genome-only study

排除标准

  • All participants:
  • 1. Diagnosed primary genetic disorder affecting connective tissue or a secondary disorder that affects connective tissue such as autoimmune diseases
  • Control group for both surgical and genome-only studies:
  • 1. First degree relative with a previously or currently diagnosed (prior to age 55) POP-Q grade 3 or 4 pelvic organ prolapse
  • Surgical group (both prolapse and controls)
  • 1.Taking anti-coagulant medications
  • 2.Any medical condition that, in the assessment of the operating surgeon, contraindicates taking a tissue biopsy

研究者

相似试验